GlassScriptPhysician profile
Ryan G Manecke
NPI 1942289129
$9,175.32
in general payments reported to CMS, 2019-2025
54 companies · $1,820 in 2025
The $1,820 reported for 2025 was more than what 78% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,471 · 2020: $520 · 2021: $823 · 2022: $1,486 · 2023: $1,335 · 2024: $1,719 · 2025: $1,820.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,790 · Education: $85.05.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,789.71 |
| Education | $85.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $953.02 | 2019-2025 | Coloplast Tfl Drive, Titan |
| Astellas Pharma US INC | $741.91 | 2019-2023 | Xtandi, Myrbetriq |
| Janssen Biotech, INC. | $492.02 | 2019-2025 | Erleada |
| Laborie Medical Technologies Corp. | $422.58 | 2020-2025 | Optilume Bph Drug Coated Balloon Catheter |
| Olympus America INC. | $389.41 | 2021-2025 | Itind System |
| Verity Pharmaceuticals INC. | $334.57 | 2022-2025 | Trelstar |
| Astrazeneca Pharmaceuticals LP | $331.01 | 2021-2025 | Lynparza |
| Neotract INC. | $322.29 | 2019-2020 | |
| Sumitomo Pharma America, INC. | $309.08 | 2024-2025 | Gemtesa, Orgovyx |
| Myriad Genetic Laboratories, INC. | $272.76 | 2022-2024 | Prolaris |
| Progenics Pharmaceuticals, INC. | $269.79 | 2022-2025 | Pylarify |
| Teleflex LLC | $267.99 | 2023-2024 | Urolift |
| Abbvie INC. | $265.46 | 2019-2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $256.66 | 2019-2025 | |
| Boston Scientific Corporation | $253.38 | 2019-2025 | Spaceoar Vue System - 10ml |
Show all 54 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Manecke listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.